ArticleHealth science reports2026
Effectiveness of COVID-19 Vaccination in Reducing Severity Among SARS-CoV-2 Infected Patients: A Prospective Study From Iraq.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effectiveness of COVID-19 Vaccination in Reducing Severity Among SARS-CoV-2 Infected Patients: A Prospective Study From Iraq.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronavirus disease 2019 (COVID-19) is a lethal global pandemic that originated in Wuhan, China at the end of 2019. As with other viral infectious diseases, the introduction of an effective vaccine is crucial for stopping the spread of the pandemic.In Iraq the COVID-19 vaccination campaign started on March 2, 2021. Aim of the Study: To determine the influence of the vaccine on new virus infection in Baghdad in terms of its effectiveness on the illness, hospitalization, and mortality. Methods: A prospective observational study of patients with SARS-CoV-2 infection who were had a newly positive Real time PCR testing for SARS-CoV-2 at Al-Yarmouk Hospital or Al-Adel Primary Health Care Center, and correlate their symptoms to their state of vaccination. Results: A total of 539 patients tested positive for COVID-19 via PCR (328 females and 211 males). Among these, 265 patients (49.2%) were vaccinated, while 274 (50.8%) were not. Being vaccinated and receiving the full doses showed the strongest association with decreased disease severity, reduced hospitalization rates, and lower mortality rates ( Conclusion: COVID-19 vaccination, while not preventing infection, markedly reduced disease severity and mortality-especially with full dosing and among high-risk groups. The differential effectiveness observed among vaccine types highlights the importance of optimizing vaccine strategies based on real-world outcomes, particularly in resource-constrained settings like Iraq.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.